http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-188763-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-00
filingDate 1981-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b90f29bfc0690eaf24439d3b02739f1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f155e1993df3d221eb7eb20ba8d2744e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddcea1902958501556a931febf1408f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c368a568a2862e188017da1c6459e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ff323e8fd361c48cd1e6e0153fbea4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e04ade255a6d664a98b2011345b48f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b168345eb9b26e7ae5d3b6b9e4bbb2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71852dbd12d8e0d35992e7aa0aa1adac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27161fc949293bd9ec7ee2536305ec8
publicationDate 1986-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-188763-B
titleOfInvention Process for preparing cys-octahydro-indolo/2,3-a/ quinolizine derivatives
abstract FIELD OF THE INVENTION The present invention relates to a novel process of optically active cis (la) and / or octahydro-indolo [2,3-a] quinolysine of the general formula: wherein R 'is a primary or secondary alkyl group having from 3 to 8 carbon atoms and R is a C1-C4 alkyl group prepared from a hexahydro-indolo [2,3-a] quinolizine salt of formula II wherein R2 is as defined above and X is an acid residue, by hydrogenation in the presence of a palladium-on-carbon catalyst such that hydrogenation in the presence of dimethylformamide. Θ ΊΓ -1-
priorityDate 1981-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414045090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426039165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415802694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411292097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414879278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18963250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20533448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456636572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4574913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420583034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592

Total number of triples: 41.